Search filters

List of works by John M. Kane

130. Meta-Analysis of Tardive Dyskinesia Rates in Randomized Controlled Studies Comparing First- to Second-Generation Antipsychotics.

scientific article

A 28-week, randomized, double-blind study of olanzapine versus aripiprazole in the treatment of schizophrenia.

scientific article published on 24 March 2009

A 6-week randomized, double-blind, placebo-controlled, comparator referenced trial of vabicaserin in acute schizophrenia

scientific article published on 24 February 2014

A Collaborative Approach to Identifying Social Media Markers of Schizophrenia by Employing Machine Learning and Clinical Appraisals.

scientific article published on 14 August 2017

A Patient-Clinician Discussion of Current Challenges in Schizophrenia Part 1: Addressing Daily Functioning and Cognitive Impairments Associated with Schizophrenia [Podcast]

scientific article published in 2023

A Patient-Clinician Discussion of Current Challenges in Schizophrenia Part 2: Negative Symptoms in Schizophrenia [Podcast]

scientific article published in 2023

A Randomized Comparison of Aripiprazole and Risperidone for the Acute Treatment of First-Episode Schizophrenia and Related Disorders: 3-Month Outcomes

scientific article

A comprehensive review of the clinical utility of and a combined analysis of the clozapine/norclozapine ratio in therapeutic drug monitoring for adult patients

scientific article published on 31 May 2019

A meta-analysis of factors associated with quality of life in first episode psychosis

scientific article published on 11 July 2018

A multicenter, randomized, double-blind, placebo-controlled, 16-week study of adjunctive aripiprazole for schizophrenia or schizoaffective disorder inadequately treated with quetiapine or risperidone monotherapy

scientific article published on October 2009

A multidose study of haloperidol decanoate in the maintenance treatment of schizophrenia

scientific article

A randomized, double-blind, placebo-controlled proof of concept study to evaluate samidorphan in the prevention of olanzapine-induced weight gain in healthy volunteers

scientific article published on 17 November 2017

Abnormal involuntary movement scale in tardive dyskinesia: Minimal clinically important difference

scientific article published on 24 June 2019

Academic highlights: guidelines for the use of long-acting injectable atypical antipsychotics

scientific article published in January 2004

Activating and Tranquilizing Effects of First-Time Treatment with Aripiprazole, Olanzapine, Quetiapine, and Risperidone in Youth

scientific article published on 19 April 2016

Adjunctive use of nonsteroidal anti-inflammatory drugs for schizophrenia: a meta-analytic investigation of randomized controlled trials

scientific article published on 29 May 2013

Akathisia: an updated review focusing on second-generation antipsychotics

scientific article

Ambiguous findings concerning potential advantages of depot antipsychotics: in search of clinical relevance

scientific article published on May 2015

Analyzing mHealth Engagement: Joint Models for Intensively Collected User Engagement Data.

scientific article

Antipsychotic augmentation vs. monotherapy in schizophrenia: systematic review, meta-analysis and meta-regression analysis

scientific article published on February 2017

Antipsychotic combinations vs monotherapy in schizophrenia: a meta-analysis of randomized controlled trials

scientific article published on 15 April 2008

Antipsychotic drug administration does not correlate with prolonged rate-corrected QT interval in children and adolescents: results from a nested case-control study

scientific article

Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics

scientific article

Antipsychotic polypharmacy: A Japanese survey of prescribers' attitudes and rationales ⬇️

scientific article published on April 18, 2013

Antipsychotic polypharmacy: A survey study of prescriber attitudes, knowledge and behavior ⬇️

scientific article published on March 21, 2011

Antipsychotic treatment and functional connectivity of the striatum in first-episode schizophrenia

scientific article

Aripiprazole once-monthly for treatment of schizophrenia: double-blind, randomised, non-inferiority study

scientific article

Aripiprazole once-monthly in the acute treatment of schizophrenia: findings from a 12-week, randomized, double-blind, placebo-controlled study

scientific article

Assessing the comparative effectiveness of long-acting injectable vs. oral antipsychotic medications in the prevention of relapse provides a case study in comparative effectiveness research in psychiatry

scientific article

Association With Hospitalization and All-Cause Discontinuation Among Patients With Schizophrenia on Clozapine vs Other Oral Second-Generation Antipsychotics: A Systematic Review and Meta-analysis of Cohort Studies

scientific article published on 31 July 2019

Association between common variants near the melanocortin 4 receptor gene and severe antipsychotic drug-induced weight gain

scientific article

Association of genetic variation in the MET proto-oncogene with schizophrenia and general cognitive ability

scientific article

Attenuated psychotic and basic symptom characteristics in adolescents with ultra-high risk criteria for psychosis, other non-psychotic psychiatric disorders and early-onset psychosis

scientific article

Authors' reply

BDNF Val66Met polymorphism and antipsychotic-induced tardive dyskinesia occurrence and severity: a meta-analysis

scientific article

Basal ganglia volumes in first-episode schizophrenia and healthy comparison subjects

scientific article published in May 2002

Baseline Characteristics and Early Response at Week 1 Predict Treatment Outcome in Adolescents With Bipolar Manic or Mixed Episode Treated With Olanzapine: Results From a 3-Week, Randomized, Placebo-Controlled Trial.

scientific article

Benign Ethnic Neutropenia and Clozapine Use: A Systematic Review of the Evidence and Treatment Recommendations

scientific article

Biological treatment of acute agitation or aggression with schizophrenia or bipolar disorder in the inpatient setting

Blood Levels to Optimize Antipsychotic Treatment in Clinical Practice: A Joint Consensus Statement of the American Society of Clinical Psychopharmacology and the Therapeutic Drug Monitoring Task Force of the Arbeitsgemeinschaft für Neuropsychopharma

scientific article published on 19 May 2020

Body mass index identified as an independent predictor of psychiatric readmission.

scientific article

COMT genotype and manic symptoms in schizophrenia

scientific article published on 7 July 2006

Can antidepressants be used to treat the schizophrenia prodrome? Results of a prospective, naturalistic treatment study of adolescents

scientific article published on 01 April 2007

Cardiometabolic risk in patients with first-episode schizophrenia spectrum disorders: baseline results from the RAISE-ETP study

scientific article published in December 2014

Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents

scientific article

Changes in Telepsychiatry Regulations during the COVID-19 Pandemic: 17 Countries and Regions' Approaches to an Evolving Healthcare Landscape

scientific article published on 27 November 2020

Characterizing Treatment Effects of Valbenazine for Tardive Dyskinesia: Additional Results From the KINECT 3 Study

scientific article published on 18 December 2018

Clinical Guidance on the Identification and Management of Treatment-Resistant Schizophrenia

scientific article published on 05 March 2019

Clinical guidelines: Dosing and switching strategies for long-acting risperidone.

scientific article published in January 2003

Clinical insights into pharmacogenetics and schizophrenia, part 2.

scientific article

Clinical predictors of response to clozapine treatment in ambulatory patients with schizophrenia.

scientific article published in May 2002

Clinical risk factors for the development of tardive dyskinesia

scientific article published on 5 February 2018

Clinically Significant Drug-Drug Interactions with Agents for Attention-Deficit/Hyperactivity Disorder

scientific article published on 01 December 2019

Clozapine Combination and Augmentation Strategies in Patients With Schizophrenia -Recommendations From an International Expert Survey Among the Treatment Response and Resistance in Psychosis (TRRIP) Working Group

scientific article published on 18 May 2020

Clozapine and "high-dose" olanzapine in refractory early-onset schizophrenia: a 12-week randomized and double-blind comparison

scientific article published on 25 July 2007

Clozapine and COVID-19: The authors respond

scientific article published on 01 July 2020

Clozapine as a first treatment for schizophrenia

scientific article published in August 2003

Clozapine in schizophrenia and its association with treatment satisfaction and quality of life: Findings of the three national surveys on use of psychotropic medications in China (2002-2012).

scientific article published on 12 August 2015

Clozapine versus "high-dose" olanzapine in refractory early-onset schizophrenia: an open-label extension study

scientific article

Cognitive improvement after treatment with second-generation antipsychotic medications in first-episode schizophrenia: is it a practice effect?

scientific article published in October 2007

Comments on Abilify MyCite

scientific article published in January 2018

Comparative mortality associated with ziprasidone and olanzapine in real-world use among 18,154 patients with schizophrenia: The Ziprasidone Observational Study of Cardiac Outcomes (ZODIAC).

scientific article published on November 2010

Comparative utility of aripiprazole and haloperidol in schizophrenia: post hoc analysis of two 52-week, randomized, controlled trials

scientific article published in January 2009

Comparison of Early Intervention Services vs Treatment as Usual for Early-Phase Psychosis: A Systematic Review, Meta-analysis, and Meta-regression

article

Completed and attempted suicides among 18,154 subjects with schizophrenia included in a large simple trial

scientific article published on March 2014

Comprehensive Versus Usual Community Care for First-Episode Psychosis: 2-Year Outcomes From the NIMH RAISE Early Treatment Program

scientific article

Consensus statement on the use of clozapine during the COVID-19 pandemic

scientific article published on 03 April 2020

Corrigendum to "Efficacy of brexpiprazole in patients with acute schizophrenia: Review of three randomized, double-blind, placebo-controlled studies" [Schizophr. Res. 174 (2016) 82-92]

scientific article published on 25 March 2017

Cost of antipsychotic polypharmacy in the treatment of schizophrenia

scientific article

Cost-Effectiveness of Comprehensive, Integrated Care for First Episode Psychosis in the NIMH RAISE Early Treatment Program

scientific article published on 31 January 2016

Cost-effective screening for the metabolic syndrome in patients treated with second-generation antipsychotic medications

scientific article

Cultural Influences in Psychiatry-Reply

scientific article published on 01 March 2020

DISC1 and neurocognitive function in schizophrenia

scientific article published in August 2005

DISC1 is associated with prefrontal cortical gray matter and positive symptoms in schizophrenia

scientific article

Demographic and clinical correlates of substance use disorders in first episode psychosis

scientific article published on 08 July 2017

Differentiation in the preonset phases of schizophrenia and mood disorders: evidence in support of a bipolar mania prodrome

scientific article published on 2 May 2007

Digital Parent Training for Children with Disruptive Behaviors: Systematic Review and Meta-Analysis of Randomized Trials

scientific article

Digital Peer-Support Platform (7Cups) as an Adjunct Treatment for Women With Postpartum Depression: Feasibility, Acceptability, and Preliminary Efficacy Study

scientific article published on 13 February 2018

Digital Peer-Support Platform (7Cups) as an Adjunct Treatment for Women With Postpartum Depression: Feasibility, Acceptability, and Preliminary Efficacy Study

Digital Peer-Support Platform (7Cups) as an Adjunct Treatment for Women With Postpartum Depression: Feasibility, Acceptability, and Preliminary Efficacy Study

Digital Trajectories to Care in First-Episode Psychosis

scientific article published on 26 September 2018

Disrupted in Schizophrenia 1 Genotype and Positive Symptoms in Schizophrenia

article

Disturbing Lack of Early Intervention Studies in Bipolar Disorder-Reply

scientific article published on 01 November 2018

Divalproex ER combined with olanzapine or risperidone for treatment of acute exacerbations of schizophrenia

scientific article

Do clozapine and risperidone affect social competence and problem solving?

scientific article published in February 2004

Does antipsychotic polypharmacy increase the risk for metabolic syndrome?

scientific article published on 27 October 2006

Dose and safety concerns of clozapine: Worldwide package inserts need revisions

scientific article published on 08 January 2020

Dr Correll and Colleagues Reply

scientific article published in September 2017

Dr. Nielsen and colleagues reply

scientific article published on 01 December 2015

Drs Kane and Correll Reply

scientific article published on 16 June 2020

Duration of Untreated Psychosis in Community Treatment Settings in the United States

scientific article published on 15 January 2015

Dysbindin genotype and negative symptoms in schizophrenia

scientific article

Early Improvement As a Predictor of Later Response to Antipsychotics in Schizophrenia: A Diagnostic Test Review

scientific article published on 5 June 2015

Early Non-Response to Antipsychotic Treatment in Schizophrenia: A Systematic Review and Meta-Analysis of Evidence-Based Management Options

scientific article published in 2023

Early Prediction of Antipsychotic Response in Schizophrenia ⬇️

scientific article published on November 1, 2003

Early identification and high-risk strategies for bipolar disorder

scientific article published on June 2007

Early nonresponse determined by the clinical global impressions scale predicts poorer outcomes in youth with schizophrenia spectrum disorders naturalistically treated with second-generation antipsychotics

scientific article

Early response or nonresponse at week 2 and week 3 predict ultimate response or nonresponse in adolescents with schizophrenia treated with olanzapine: results from a 6-week randomized, placebo-controlled trial.

scientific article

Early response to antipsychotic drug therapy as a clinical marker of subsequent response in the treatment of schizophrenia

scientific article

Effect of Long-Acting Injectable Antipsychotics vs Usual Care on Time to First Hospitalization in Early-Phase Schizophrenia: A Randomized Clinical Trial

scientific article published on 15 July 2020

Effectiveness of Long-Acting Injectable vs Oral Antipsychotics in Patients With Schizophrenia: A Meta-analysis of Prospective and Retrospective Cohort Studies

scientific article published on 01 April 2018

Effectiveness of a cognitive behavioral weight management intervention in obese patients with psychotic disorders compared to patients with nonpsychotic disorders or no psychiatric disorders: results from a 12-month, real-world study

scientific article

Effectiveness of lurasidone vs. quetiapine XR for relapse prevention in schizophrenia: a 12-month, double-blind, noninferiority study

scientific article published on 11 April 2013

Effects of aripiprazole once-monthly on domains of personal and social performance: results from 2 multicenter, randomized, double-blind studies

scientific article

Efficacy and Safety of Cariprazine in Acute Exacerbation of Schizophrenia: Results From an International, Phase III Clinical Trial.

scientific article published in August 2015

Efficacy and Safety of Lumateperone for Treatment of Schizophrenia: A Randomized Clinical Trial

scientific article published on 08 January 2020

Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder.

scientific article published in September 2002

Efficacy and safety of blonanserin transdermal patch in patients with schizophrenia: A 6-week randomized, double-blind, placebo-controlled, multicenter study

scientific article published on 27 August 2019

Efficacy and safety of individual second-generation vs. first-generation antipsychotics in first-episode psychosis: a systematic review and meta-analysis

scientific article

Efficacy and tolerability of clozapine in Japanese patients with treatment-resistant schizophrenia: results from a 12-week, flexible dose study using raters masked to antipsychotic choice.

scientific article

Efficacy and tolerability of ziprasidone in patients with treatment-resistant schizophrenia

scientific article published in January 2006

Efficacy for Psychopathology and Body Weight and Safety of Topiramate-Antipsychotic Cotreatment in Patients With Schizophrenia Spectrum Disorders: Results From a Meta-Analysis of Randomized Controlled Trials

scientific article published on June 2016

Efficacy of Atypical Antipsychotics in the Management of Acute Agitation and Aggression in Hospitalized Patients with Schizophrenia or Bipolar Disorder: Results from a Systematic Review

scientific article

Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Schizophrenia or Schizoaffective Disorder

scientific article

Efficacy of brexpiprazole in patients with acute schizophrenia: Review of three randomized, double-blind, placebo-controlled studies

scientific article published on 3 May 2016

Elevated blood urea nitrogen and medical outcome of psychiatric inpatients

scientific article published in March 2014

Enlight: A Comprehensive Quality and Therapeutic Potential Evaluation Tool for Mobile and Web-Based eHealth Interventions.

scientific article published on 21 March 2017

Epidemiology, Prevention, and Assessment of Tardive Dyskinesia and Advances in Treatment

scientific article

Equally increased risk for metabolic syndrome in patients with bipolar disorder and schizophrenia treated with second-generation antipsychotics

scientific article published in November 2008

Evaluation of akathisia in patients with schizophrenia, schizoaffective disorder, or bipolar I disorder: a post hoc analysis of pooled data from short- and long-term aripiprazole trials

scientific article

Examining Predictors of Real-World User Engagement with Self-Guided eHealth Interventions: Analysis of Mobile Apps and Websites Using a Novel Dataset

article

Expanding phenomenologic heterogeneity of tardive syndromes: Time for an updated assessment tool

scientific article published on 30 June 2020

First Experience With a Wireless System Incorporating Physiologic Assessments and Direct Confirmation of Digital Tablet Ingestions in Ambulatory Patients With Schizophrenia or Bipolar Disorder

scientific article published on June 1, 2013

Frequency and correlates of DSM-5 attenuated psychosis syndrome in a sample of adolescent inpatients with nonpsychotic psychiatric disorders

scientific article

Genetic variation in DTNBP1 influences general cognitive ability

scientific article published on 13 January 2006

Genomics and the future of pharmacotherapy in psychiatry

scientific article published on October 2007

Hospitalisation rates in patients switched from oral anti-psychotics to aripiprazole once-monthly for the management of schizophrenia ⬇️

scientific article published on May 28, 2013

Hospitalization rates in patients switched from oral anti-psychotics to aripiprazole once-monthly: final efficacy analysis

scientific article published on 10 November 2014

ITI-007 for the Treatment of Schizophrenia: A 4-Week Randomized, Double-Blind, Controlled Trial.

scientific article

Identification of high-risk coronary heart disease patients receiving atypical antipsychotics: single low-density lipoprotein cholesterol threshold or complex national standard?

scientific article published in April 2008

Identifying patients and clinical scenarios for use of long-acting injectable antipsychotics - expert consensus survey part 1.

scientific article

Impairments in perceptual competency and maintenance on a visual delayed match-to-sample test in first-episode schizophrenia

scientific article published in March 2003

Incidence of tardive dyskinesia with risperidone or olanzapine in the elderly: results from a 2-year, prospective study in antipsychotic-naïve patients

scientific article

Initiating/maintaining long-acting injectable antipsychotics in schizophrenia/schizoaffective or bipolar disorder - expert consensus survey part 2.

scientific article

Insulin secretion in patients receiving clozapine, olanzapine, quetiapine and risperidone ⬇️

scientific article published on 09 December 2012

Iron homeostasis alterations and risk for akathisia in patients treated with antipsychotics: A systematic review and meta-analysis of cross-sectional studies

scientific article published on 19 May 2020

Is Transcultural Psychiatry Possible?

scientific article published on 14 November 2019

Issues and perspectives in designing clinical trials for negative symptoms in schizophrenia

scientific article

Lack of an inverse relationship between duration of untreated psychosis and cognitive function in first episode schizophrenia

scientific article

Lack of effect of stimulant combination with second-generation antipsychotics on weight gain, metabolic changes, prolactin levels, and sedation in youth with clinically relevant aggression or oppositionality

scientific article

Left middle temporal gyrus activation during a phonemic discrimination task

scientific article

Lessons learned in the conduct of a global, large simple trial of treatments indicated for schizophrenia ⬇️

scientific article published on December 12, 2012

Long-Term Safety and Tolerability of Valbenazine (NBI-98854) in Subjects with Tardive Dyskinesia and a Diagnosis of Schizophrenia or Mood Disorder

scientific article published on August 2017

Long-acting injectable risperidone: efficacy and safety of the first long-acting atypical antipsychotic

scientific article published in June 2003

Long-acting injectable versus oral antipsychotics in schizophrenia: a systematic review and meta-analysis of mirror-image studies

scientific article

Long-acting injectable vs oral antipsychotics for relapse prevention in schizophrenia: a meta-analysis of randomized trials

scientific article published on 17 December 2012

Long-term effectiveness of oral second-generation antipsychotics in patients with schizophrenia and related disorders: a systematic review and meta-analysis of direct head-to-head comparisons

scientific article published on 01 June 2019

Long-term efficacy and safety of iloperidone: results from 3 clinical trials for the treatment of schizophrenia

scientific article

Long-term safety and tolerability of aripiprazole once-monthly in maintenance treatment of patients with schizophrenia ⬇️

scientific article published on July 1, 2013

Longitudinal associations of family burden and patient quality of life in the context of first-episode schizophrenia in the RAISE-ETP study

scientific article published on 16 April 2019

Low Incidence of Neuroleptic Malignant Syndrome Associated With Paliperidone Palmitate Long-Acting Injectable: A Database Report and Case Study

Low-density lipoprotein cholesterol in patients treated with atypical antipsychotics: missed targets and lost opportunities

scientific article published on 06 March 2007

Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies

scientific article (publication date: March 2004)

M16. Valbenazine (NBI-98854) for the Treatment of Tardive Dyskinesia: Analysis by Underlying Psychiatric Diagnosis in Phase III KINECT 3 Study.

scientific article

Medical outcome of psychiatric inpatients with admission hyponatremia ⬇️

scientific article published on March 14, 2012

Metabolic effects of treatment with atypical antipsychotics

scientific article published on 01 November 2004

Metabolic syndrome and the risk of coronary heart disease in 367 patients treated with second-generation antipsychotic drugs

scientific article published in April 2006

Molecular differentiation of schizoaffective disorder from schizophrenia using BDNF haplotypes

scientific article published on April 2009

Neurocognitive profile in adolescents with early-onset schizophrenia: clinical correlates

scientific article published on 14 July 2005

Neuromotor Adverse Effects in 342 Youth During 12 Weeks of Naturalistic Treatment With 5 Second-Generation Antipsychotics

scientific article published on 7 July 2015

Neuropsychological Test Performance to Enhance Identification of Subjects at Clinical High Risk for Psychosis and to Be Most Promising for Predictive Algorithms for Conversion to Psychosis: A Meta-Analysis

scientific article published on January 2017

Non-adherence to medication in patients with psychotic disorders: epidemiology, contributing factors and management strategies

scientific article published on October 2013

O5.5. PSYCHOTIC RELAPSE DURING MAINTENANCE ANTIPSYCHOTIC TREATMENT: A NATIONWIDE STUDY

O7.2. BREAKTHROUGH ON ANTIPSYCHOTIC MAINTENANCE MEDICATION IN A CLINICAL COHORT.

scientific article published in April 2018

Obesity and coronary risk in patients treated with second-generation antipsychotics ⬇️

scientific article published on December 12, 2010

Objective User Engagement With Mental Health Apps: Systematic Search and Panel-Based Usage Analysis

scientific article published on 25 September 2019

Olanzapine long-acting injection: a 24-week, randomized, double-blind trial of maintenance treatment in patients with schizophrenia

scientific article published on 15 December 2009

One-year incidence rates of tardive dyskinesia in children and adolescents treated with second-generation antipsychotics: a systematic review

scientific article published on October 2007

Optimizing Treatment Choices to Improve Adherence and Outcomes in Schizophrenia

scientific article published on 17 September 2019

Outcome of Youth with Early-Phase Schizophrenia-Spectrum Disorders and Psychosis Not Otherwise Specified Treated with Second-Generation Antipsychotics: 12 Week Results from a Prospective, Naturalistic Cohort Study

scientific article

Outcomes of Neuroleptic Malignant Syndrome With Depot Versus Oral Antipsychotics: A Systematic Review and Pooled, Patient-Level Analysis of 662 Case Reports

scientific article published on 24 November 2020

Overview of short- and long-term tolerability and safety of brexpiprazole in patients with schizophrenia

scientific article

PM421. Efficacy and safety of brexpiprazole (OPC-34712) in acute schizophrenia: a pooled analysis of two pivotal studies.

scientific article published on 27 May 2016

Past and Present Progress in the Pharmacologic Treatment of Schizophrenia ⬇️

scientific article published on September 1, 2010

Patients' Attitudes Towards Telepsychiatry: Results of a Nationwide, Multisite Survey During the COVID-19 Pandemic

scientific article published on 01 December 2020

Patterns of stress in schizophrenia

scientific article published on 2 June 2008

Performance Improvement CME: Managing Schizophrenia

scientific article published on 01 October 2011

Pharmacoepidemiology of antipsychotic use in youth with ADHD: trends and clinical implications

scientific article

Pharmacogenetic Associations of Antipsychotic Drug-Related Weight Gain: A Systematic Review and Meta-analysis

scientific article published on 23 May 2016

Pharmacokinetics, tolerability and safety of aripiprazole once-monthly in adult schizophrenia: an open-label, parallel-arm, multiple-dose study

scientific article published on 23 July 2013

Pharmacologic treatment of schizophrenia

scientific article

Plasma levels of second-generation antipsychotics and clinical response in acute psychosis: A review of the literature ⬇️

scientific article published on 09 May 2013

Predicting Early Warning Signs of Psychotic Relapse From Passive Sensing Data: An Approach Using Encoder-Decoder Neural Networks

scientific article published on 31 August 2020

Predicting antipsychotic drug response - replication and extension to six weeks in an international olanzapine study

scientific article

Predicting response to atypical antipsychotics based on early response in the treatment of schizophrenia

scientific article published on 18 April 2008

Predictors of psychosis breakthrough during 24 months of long-acting antipsychotic maintenance treatment in first episode schizophrenia

scientific article published on 22 November 2019

Predictors of remission, schizophrenia, and bipolar disorder in adolescents with brief psychotic disorder or psychotic disorder not otherwise specified considered at very high risk for schizophrenia

scientific article published on October 2008

Prescription practices in the treatment of first-episode schizophrenia spectrum disorders: data from the national RAISE-ETP study

scientific article

Prevalence and correlates of antipsychotic polypharmacy: a systematic review and meta-regression of global and regional trends from the 1970s to 2009.

scientific article

Proceedings and data from The Schizophrenia Summit: a critical appraisal to improve the management of Schizophrenia.

scientific article published in January 2009

Psychological well-being and mental health recovery in the NIMH RAISE early treatment program

scientific article published on 29 November 2016

Psychopharmacological Treatment in the RAISE-ETP Study: Outcomes of a Manual and Computer Decision Support System Based Intervention

scientific article published on 15 September 2017

Psychosis breakthrough on antipsychotic maintenance medication (BAMM): what can we learn?

scientific article published on 11 October 2017

Psychosis relapse during treatment with long-acting injectable antipsychotics in individuals with schizophrenia-spectrum disorders: an individual participant data meta-analysis

scientific article published on 01 September 2020

QT Interval Duration and Dispersion in Children and Adolescents Treated With Ziprasidone ⬇️

scientific article published on March 8, 2011

Quantifying Clinical Relevance in the Treatment of Schizophrenia ⬇️

scientific article published on December 1, 2011

Randomized controlled trials in schizophrenia: opportunities, limitations, and trial design alternatives ⬇️

scientific article published on January 1, 2011

Ranking Antipsychotics for Efficacy and Safety in Schizophrenia

scientific article published on 06 November 2019

Rapid clozapine titration in treatment-refractory bipolar disorder

scientific article

Real‐world effectiveness of clozapine in patients with bipolar disorder: results from a 2‐year mirror‐image study ⬇️

scientific article published on October 26, 2012

Relapse prevention in schizophrenia with new-generation antipsychotics: a systematic review and exploratory meta-analysis of randomized, controlled trials.

scientific article

Relationship of Cognition to Clinical Response in First-Episode Schizophrenia Spectrum Disorders

scientific article

Revisiting the Abnormal Involuntary Movement Scale: Proceedings From the Tardive Dyskinesia Assessment Workshop

scientific article published on 01 May 2018

Risk factors for medical deterioration of psychiatric inpatients: opportunities for early recognition and prevention ⬇️

scientific article published on April 18, 2012

Role of social media and the Internet in pathways to care for adolescents and young adults with psychotic disorders and non-psychotic mood disorders

scientific article published on 23 March 2015

Runs of homozygosity reveal highly penetrant recessive loci in schizophrenia.

scholarly article

SA17. Response to Treatment With Valbenazine (NBI-98854) in Subjects With Tardive Dyskinesia.

scientific article published on 20 March 2017

SU1. Tardive Dyskinesia Prevalence in the Period of Second-Generation Antipsychotic Use: A Meta-Analysis.

scientific article

SU14. Characteristics Associated With Relapse in Patients With Schizophrenia: Post Hoc Analysis of a Randomized, Double-Blind, Placebo-Controlled, Cariprazine Relapse Prevention Trial.

scientific article published on 20 March 2017

Safety and tolerability of antipsychotic co-treatment in patients with schizophrenia: results from a systematic review and meta-analysis of randomized controlled trials

scientific article published on 11 March 2016

Safety and tolerability of antipsychotic polypharmacy ⬇️

scientific article published on May 8, 2012

Safety and tolerability of cariprazine in patients with acute exacerbation of schizophrenia: a pooled analysis of four phase II/III randomized, double-blind, placebo-controlled studies

scientific article published on 07 July 2017

Safety and tolerability of long-acting injectable versus oral antipsychotics: A meta-analysis of randomized controlled studies comparing the same antipsychotics

scientific article

Schizophrenia

article

Schizophrenia Polygenic Risk Score as a Predictor of Antipsychotic Efficacy in First-Episode Psychosis

scientific article published on 05 November 2018

Schizophrenia: mechanism of action of current and novel treatments

scientific article published on April 2014

Serotonin 6 receptor gene and schizophrenia: case-control study and meta-analysis

scientific article published in January 2012

Sex differences in frontal lobe white matter microstructure: a DTI study

scientific article published in December 2003

Smaller anterior hippocampal formation volume in antipsychotic-naive patients with first-episode schizophrenia

scientific article published in December 2003

Structural similarity networks predict clinical outcome in early-phase psychosis

scientific article published on 24 January 2019

Subcortical modulation of attentional control by second-generation antipsychotics in first-episode psychosis

scientific article published on 10 October 2013

Sudden deaths in psychiatric patients

scientific article published on 3 May 2011

Sudden unexpected death in schizophrenia: autopsy findings in psychiatric inpatients

scientific article published on 04 April 2014

Suicidality and hospitalization as cause and outcome of pediatric psychiatric emergency room visits

scientific article

T234. BREAKTHROUGH ON ANTIPSYCHOTIC MAINTENANCE MEDICATION: A STUDY-LEVEL META-ANALYSIS AND META-REGRESSION ANALYSIS.

scientific article published in April 2018

Tardive Dyskinesia Prevalence in the Period of Second-Generation Antipsychotic Use: A Meta-Analysis

scientific article published on 31 January 2017

Tardive dyskinesia among Chinese and Malay patients with schizophrenia

scientific article published in February 2002

Tardive dyskinesia and impaired glucose tolerance

scientific article published in August 2002

Tardive dyskinesia risk with first- and second-generation antipsychotics in comparative randomized controlled trials: a meta-analysis

article by Maren Carbon et al published October 2018 in World Psychiatry

Technology-Assisted Parent Training Programs for Children and Adolescents With Disruptive Behaviors: A Systematic Review.

scientific article

Termination of clozapine treatment due to medical reasons: when is it warranted and how can it be avoided?

scientific article

The Mount Sinai conference on the pharmacotherapy of schizophrenia

scientific article

The Neurobiology of Treatment-Resistant Schizophrenia: Paths to Antipsychotic Resistance and A Roadmap for Future Research

scientific article published on 01 October 2020

The QTc interval and its dispersion in patients receiving two atypical antipsychotics

scientific article published on 20 June 2008

The RAISE early treatment program for first-episode psychosis: background, rationale, and study design

scientific article published on March 2015

The Relationship Between Acoustic Startle Response Measures and Cognitive Functions in Japanese Patients with Schizophrenia ⬇️

scientific article published on March 28, 2012

The Role of Clozapine in Treatment-Resistant Schizophrenia

scientific article published on 01 March 2016

The Use of Long-Acting Injectable Antipsychotics in Schizophrenia: Evaluating the Evidence

scientific article

The Ziprasidone Observational Study of Cardiac Outcomes (ZODIAC): design and baseline subject characteristics.

scientific article published on January 2008

The efficacy of aripiprazole in the treatment of multiple symptom domains in patients with acute schizophrenia: a pooled analysis of data from the pivotal trials

scientific article

The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.

scientific article published on January 2003

The field of schizophrenia: strengths, weaknesses, opportunities, and threats

scientific article published on 18 November 2011

The future of pharmacotherapy for schizophrenia

scientific article published on June 2003

The genetics of symptom-based phenotypes: toward a molecular classification of schizophrenia

scientific article published on 15 July 2008

The neurobiology of treatment-resistant schizophrenia: paths to antipsychotic resistance and a roadmap for future research

scientific article published on 07 January 2020

The serotonin 1A receptor gene confer susceptibility to mood disorders: results from an extended meta-analysis of patients with major depression and bipolar disorder

scientific article published on 03 July 2012

Transforming the Treatment of Schizophrenia in the United States: The RAISE Initiative

scientific article

Treatment models and designs for intervention research during the psychotic prodrome

scientific article published on January 2003

Treatment of tardive dyskinesia with VMAT-2 inhibitors: a systematic review and meta-analysis of randomized controlled trials.

scientific article

Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology

scientific article published on 6 December 2016

Use of remote centralized raters via live 2-way video in a multicenter clinical trial for schizophrenia

scientific article published in December 2008

Utilizing Machine Learning on Internet Search Activity to Support the Diagnostic Process and Relapse Detection in Young Individuals With Early Psychosis: Feasibility Study

scientific article published on 01 September 2020

Variants in the DRD2 locus and antipsychotic-related prolactin levels: A meta-analysis

scientific article published on 6 June 2016

When can patients with potentially life-threatening adverse effects be rechallenged with clozapine? A systematic review of the published literature ⬇️

scientific article published on November 22, 2011

White matter changes associated with antipsychotic treatment in first-episode psychosis

scientific article published on 16 October 2013

Why do clinical trials fail? The problem of measurement error in clinical trials: time to test new paradigms?

scientific article published in February 2007

mHealth for Schizophrenia: Patient Engagement With a Mobile Phone Intervention Following Hospital Discharge

scientific article

ω-3 Polyunsaturated Fatty Acids to Prevent Psychosis: The Importance of Replication Studies

scientific article published in January 2017

Paulina is supported by:

About Paulina

Help